Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Trials conducted between 2001 and 2007 demonstrated statistically significant reductions in body fat, although the larger Phase IIb OPTIONS trial did not replicate these findings at sufficient magnitude for regulatory approval, and formal development was discontinued in 2007
Studied in preclinical models of tissue regeneration, angiogenesis, inflammatory signaling and gastrointestinal integrity
Phentermine can be a safe, useful tool in the right hands with the right screening
For broader context on immune peptides, see our comparison of LL-37 vs Thymosin Alpha-1 and our profiles on KPV and epitalon
BPC-157 Injection Quick Facts Route Subcutaneous (under the skin, not into muscle) Standard Sites Abdomen, thigh, upper glute, back of deltoid Most Common Site Abdomen (consistent absorption, easy to see) Needle 27-31 gauge insulin syringe, 1/2 inch length Volume Small, typically 0.1-0.3 mL per injection Ships BPC-157 Is a Subcutaneous Injection Where to inject BPC-157: the abdomen, thigh, upper outer glute, or back of the arm
